A nurse is reviewing a client's medical history before administering a new prescription for atropine. Which of the following client conditions is contraindicated?

A) "Refusing the injection means you will not get better."
This response may induce fear or anxiety in the client and is not therapeutic. It does not address the client's concerns and does not provide information about alternative treatment options.

B) "You should not feel anything more than a minor sting from the injection."
While this statement aims to reassure the client, it may not alleviate their fear of needles. Additionally, it may not accurately reflect the client's experience, as pain perception varies among individuals. Furthermore, focusing solely on the injection's pain level may not address the client's underlying fear of needles.

C) "I will discuss other treatment options with your provider."
This response acknowledges the client's fear of needles and indicates the nurse's willingness to explore alternative treatment options. It promotes open communication and collaboration between the nurse, client, and healthcare provider to find a suitable solution that addresses the client's concerns while effectively treating the infection.

D) "You must take this medication because there is no other option to treat this infection."
This response may increase the client's anxiety and resistance to treatment. It does not respect the client's autonomy or address their fear of needles. Additionally, there may be alternative treatment options available that the client could consider with the guidance of their healthcare provider.

Answer: C. "Ensure that the air bubble remains in the syringe."

A. "Inject the medication into the lateral thigh."
This is incorrect for enoxaparin administration. Enoxaparin, a low-molecular-weight heparin, should be injected into the subcutaneous tissue of the abdomen, preferably in the fatty tissue around the navel or the outer aspects of the abdomen, to ensure proper absorption.

B. "Release the skin fold before injecting the medication."
This is incorrect. The skin fold should be held throughout the injection to ensure that the medication is delivered into the subcutaneous tissue and not the muscle. Releasing the skin fold too early may risk deeper muscle injection.

C. "Ensure that the air bubble remains in the syringe."
This is the correct practice for enoxaparin injections. The air bubble in the prefilled syringe is intended to ensure that the entire dose of medication is delivered and to prevent leakage of the medication from the injection site. It also helps to clear the needle of medication after injection.

D. "Rub the site after injecting the medication."
This is incorrect. Rubbing the site after administering enoxaparin can increase the risk of bruising and tissue irritation, as enoxaparin is an anticoagulant that can increase bleeding tendencies. It is recommended to avoid rubbing the site after injection.